Literature DB >> 12000723

Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis.

Andras Komocsi1, Peter Lamprecht, Elena Csernok, Antje Mueller, Konstanze Holl-Ulrich, Ulrike Seitzer, Frank Moosig, Armin Schnabel, Wolfgang Ludwig Gross.   

Abstract

To elucidate whether the fraction of CD28(-) T cells within the CD4(+) T-cell population is a major source of Th1-like and proinflammatory cytokine production driving Wegener's granulomatosis (WG) granuloma formation, we analyzed the phenotype and functional characteristics of peripheral blood CD4(+)CD28(-) T cells and of T cells in granulomatous lesions of 12 patients with active WG. Surface markers and intracytoplasmic cytokine and perforin expression were assessed by flow cytometry. Cytokine secretion was measured by enzyme-linked immunosorbent assay. Immunohistological studies demonstrated interferon-gamma and tumor necrosis factor-alpha cytokine positivity attributable to CD4(+)CD28(-) T cells in granulomatous lesions. Peripheral blood CD4(+)CD28(-) T cells expressed CD57, also found on natural killer cells, and intracytoplasmic perforin. They were generally CD25 (interleukin-2 receptor)-negative. CD18 (adhesion molecule beta(2)-integrin) was strongly up-regulated on CD4(+)CD28(-) T cells, whereas only a minority of CD4(+)CD28(+) T cells expressed CD18. CD4(+)CD28(-) T cells appeared as a major source of interferon-gamma and tumor necrosis factor-alpha. In contrast, CD4(+)CD28(+) T cells were able to produce and secrete a wider variety of cytokines including interleukin-2. One-quarter of CD4(+)CD28(+) T cells expressed the activation marker CD25, but they lacked perforin. Thus, CD4(+)CD28(-) T cells appeared more differentiated than CD4(+)CD28(+) T cells. They displayed Th1-like cytokine production and features suggestive of the capability of CD4(+) T-cell-mediated cytotoxicity. CD4(+)CD28(-) T cells may be recruited into granulomatous lesions from the blood via CD18 interaction, and may subsequently promote monocyte accumulation and granuloma formation through their cytokine secretion in WG.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12000723      PMCID: PMC1850873          DOI: 10.1016/s0002-9440(10)61118-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  41 in total

1.  A human in vitro granuloma model using heat killed Candida albicans cells immobilized on plastic culture wells.

Authors:  D E Heinemann; J H Peters; M Gahr
Journal:  Scand J Immunol       Date:  1997-06       Impact factor: 3.487

Review 2.  Cytokines in the induction and expression of T-cell-mediated granuloma formation and protection in the murine model of listeriosis.

Authors:  M E Mielke; C Peters; H Hahn
Journal:  Immunol Rev       Date:  1997-08       Impact factor: 12.988

Review 3.  Interleukin 2 and its receptors: recent advances and new immunological functions.

Authors:  J Thèze; P M Alzari; J Bertoglio
Journal:  Immunol Today       Date:  1996-10

4.  Active Wegener's granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10.

Authors:  B R Lúdvíksson; M C Sneller; K S Chua; C Talar-Williams; C A Langford; R O Ehrhardt; A S Fauci; W Strober
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

5.  Co-stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28- T cells.

Authors:  W Park; C M Weyand; D Schmidt; J J Goronzy
Journal:  Eur J Immunol       Date:  1997-05       Impact factor: 5.532

Review 6.  Perforin and lymphocyte-mediated cytolysis.

Authors:  C C Liu; P M Persechini; J D Young
Journal:  Immunol Rev       Date:  1995-08       Impact factor: 12.988

7.  Up-regulation of the endothelial cell adhesion molecule intercellular adhesion molecule-1 (ICAM-1) by autoantibodies in autoimmune vasculitis.

Authors:  P A Johnson; H D Alexander; S A McMillan; A P Maxwell
Journal:  Clin Exp Immunol       Date:  1997-05       Impact factor: 4.330

8.  Recall response to cytomegalovirus in allograft recipients: mobilization of CD57+, CD28+ cells before expansion of CD57+, CD28- cells within the CD8+ T lymphocyte compartment.

Authors:  M Hazzan; M Labalette; C Noel; G Lelievre; J P Dessaint
Journal:  Transplantation       Date:  1997-03-15       Impact factor: 4.939

9.  Expanded T cell populations in patients with Wegener's granulomatosis: characteristics and correlates with disease activity.

Authors:  R Giscombe; S Nityanand; N Lewin; J Grunewald; A K Lefvert
Journal:  J Clin Immunol       Date:  1998-11       Impact factor: 8.317

10.  Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells.

Authors:  F Moosig; E Csernok; G Wang; W L Gross
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

View more
  54 in total

1.  Active Crohn's disease patients show a distinctive expansion of circulating memory CD4+CD45RO+CD28null T cells.

Authors:  Jaime García de Tena; Luis Manzano; Juan Carlos Leal; Esther San Antonio; Verónica Sualdea; Melchor Alvarez-Mon
Journal:  J Clin Immunol       Date:  2004-03       Impact factor: 8.317

Review 2.  [T-cells in ANCA-associated vasculitis].

Authors:  P Lamprecht; D Kabelitz
Journal:  Z Rheumatol       Date:  2011-10       Impact factor: 1.372

3.  Relationship between serum levels of macrophage migration inhibitory factor and the activity of antineutrophil cytoplasmic antibody-associated vasculitides.

Authors:  Heidemarie Becker; Christian Maaser; Eva Mickholz; Anke Dyong; Wolfram Domschke; Markus Gaubitz
Journal:  Clin Rheumatol       Date:  2006-01-04       Impact factor: 2.980

Review 4.  Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides.

Authors:  P Lamprecht
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

5.  Successful treatment of meningeal involvement in Wegener's granulomatosis with infliximab.

Authors:  J Hermann; P Reittner; M Scarpatetti; W Graninger
Journal:  Ann Rheum Dis       Date:  2006-05       Impact factor: 19.103

Review 6.  Wegener's granulomatosis: is biologic therapy useful?

Authors:  Pasha Sarraf; Jonathan Kay; Robert P Friday; Anthony M Reginato
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

Review 7.  Wegener's granulomatosis: the current view.

Authors:  Frank Moosig; Peter Lamprecht; Wolfgang L Gross
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

8.  CD28 down-regulation on CD4 T cells is a marker for graft dysfunction in lung transplant recipients.

Authors:  Sean M Studer; M Patricia George; Xuehai Zhu; Yifang Song; Vincent G Valentine; Michael W Stoner; Jigme Sethi; Chad Steele; Steven R Duncan
Journal:  Am J Respir Crit Care Med       Date:  2008-07-10       Impact factor: 21.405

9.  The expression of molecule CD28 and CD38 on CD4⁺/CD8⁺ T lymphocytes in thymus and spleen elicited by Schistosoma japonicum infection in mice model.

Authors:  Na Li; Peng-yu Ji; Lan-gui Song; Jun-xia Lei; Zhi-yue Lv; Zhong-dao Wu; Xiao Shao; Xi Sun
Journal:  Parasitol Res       Date:  2015-05-24       Impact factor: 2.289

Review 10.  [Wegener's granulomatosis and microscopic polyangiitis].

Authors:  K de Groot; E Reinhold-Keller
Journal:  Z Rheumatol       Date:  2009-02       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.